- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Nebulized ipratropium bromide
Total 1186 results
-
Assistance Publique - Hôpitaux de ParisWithdrawnPulmonary Arterial Hypertension
-
Sunovion Respiratory Development Inc.CompletedChronic Obstructive Pulmonary DiseaseUnited States, United Kingdom
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic Obstructive
-
Laval UniversityInstitut universitaire de cardiologie et de pneumologie de Québec, University...UnknownChronic Obstructive Pulmonary DiseaseCanada
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic Obstructive
-
Sultan Abdulhamid Han Training and Research Hospital...Recruiting
-
Imperial College LondonGlaxoSmithKlineTerminatedChronic Obstructive Pulmonary DiseaseUnited Kingdom
-
State University of New York at BuffaloNational Center for Advancing Translational Sciences (NCATS)CompletedDepression | Asthma | Childhood AsthmaUnited States
-
Boehringer IngelheimCompleted
-
University Health Network, TorontoParkinson's Disease FoundationCompleted
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States
-
Hat Yai Medical Education CenterRecruitingAsthma | Airway Obstruction | Airway Remodeling | Parasympathetic Nervous System DiseasesThailand
-
University of California, San FranciscoCompletedBronchospasm, Exercise-InducedUnited States
-
Haukeland University HospitalCompletedExercise Induced Laryngeal Obstruction (EILO)Norway
-
London Health Sciences CentreUnknown
-
GlaxoSmithKlineUniversity College London HospitalsCompletedLung Diseases, InterstitialUnited Kingdom
-
Queen's UniversityCompletedChronic Obstructive Pulmonary Disease (COPD)Canada
-
Boehringer IngelheimCompleted
-
University of SaskatchewanRoyal University Hospital FoundationCompleted
-
University of California, Los AngelesMylan Pharmaceuticals Inc; Theravance BiopharmaRecruitingCOPD | Acute Respiratory FailureUnited States
-
Boehringer IngelheimCompleted
-
Daewoong Pharmaceutical Co. LTD.Completed
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic Obstructive
-
Centre for Addiction and Mental HealthCompleted
-
Pearl Therapeutics, Inc.CompletedChronic Obstructive Pulmonary DiseaseUnited States
-
AstraZenecaCompletedChronic Obstructive Pulmonary DiseaseUnited States, Canada
-
AstraZenecaCompletedChronic Obstructive Pulmonary DiseaseUnited States, Canada
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States, Argentina, Lithuania, Slovakia, United Kingdom
-
ThromboGenicsBacchus VascularTerminatedDeep Vein ThrombosisIreland
-
AstraZenecaMenarini GroupCompletedPulmonary Disease, Chronic ObstructiveItaly, Spain, United Kingdom, Germany, Hungary
-
AstraZenecaCompletedPulmonary Disease, Chronic ObstructiveUnited States, Canada
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)United States, Argentina, Australia, Canada, Mexico, New Zealand, South Africa
-
Laval UniversityMcGill University; Boehringer IngelheimCompletedChronic Obstructive Pulmonary DiseaseCanada
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease | COPD | Moderate to Very Severe COPDUnited States, Canada
-
AstraZenecaCompletedChronic Obstructive Pulmonary DiseaseUnited States, Canada
-
AstraZenecaCompletedA Trial Assessing LAS34273 in Moderate to Severe Stable Chronic Obstructive Pulmonary Disease (COPD)Chronic Obstructive Pulmonary Disease (COPD)Andorra, Austria, Belgium, Bulgaria, Czech Republic, Denmark, France, Germany, Hungary, Italy, Netherlands, Poland, Romania, Russian Federation, Spain, United Kingdom
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)Germany, Spain, United Kingdom
-
Botanix PharmaceuticalsCompletedPrimary Axillary HyperhidrosisUnited States
-
ThromboGenicsTerminatedArterial Occlusive DiseasesBelgium
-
AstraZenecaCompletedChronic Obstructive Pulmonary DiseaseUnited States, Canada
-
AstraZenecaCompleted
-
Rain Oncology IncTerminatedNSCLC Stage IIIB | NSCLC, Recurrent | NRG1 Fusion | EGFR Exon 20 Insertion Mutation | NSCLC, Stage IIIC | NSCLC, Stage IV | HER2-activating Mutation | ERBB FusionUnited States, Canada, Hong Kong
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)Germany, Czech Republic, France, Hungary, Italy, Peru, Poland, Russian Federation, South Africa, Spain, Ukraine
-
NycomedCompleted
-
Cothera Bioscience, IncRecruitingLymphoma, B-Cell | Lymphoma, Large B-Cell, Diffuse | Lymphatic Diseases | Burkitt Lymphoma | High-grade B-cell Lymphoma | C-MYC/BCL6 Double-Hit High-Grade B-Cell Lymphoma | C-MYC/BCL2 Double-Hit High-Grade B-Cell Lymphoma | Lymphoma, High-Grade | C-Myc Gene RearrangementKorea, Republic of, China
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
NPO PetrovaxCompletedInfections, CoronavirusBelarus, Russian Federation
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveChina, Korea, Republic of
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)Germany